<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05081817</url>
  </required_header>
  <id_info>
    <org_study_id>190045</org_study_id>
    <nct_id>NCT05081817</nct_id>
  </id_info>
  <brief_title>Accuracy Comparison of Two CGMs in Hospitalized Patients</brief_title>
  <official_title>Comparative Accuracy of Two Subcutaneous Continuous Glucose Monitoring Devices in Hospitalized Patients Requiring Continuous Intravenous Insulin Infusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DexCom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the accuracy of two different continuous blood sugar&#xD;
      monitoring systems in hospitalized patients by comparing them standard laboratory blood sugar&#xD;
      testing in the hospital.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in glucose measurement</measure>
    <time_frame>5 Days</time_frame>
    <description>Difference between glucose as measured by continuous glucose monitor versus laboratory</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>ICU</arm_group_label>
    <description>ICU patients on insulin drip</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ICU patients requiring an insulin drip.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. All genders, admitted to UC San Diego Hillcrest Medical Center with an anticipated&#xD;
             remaining length of stay of ≥24 hours&#xD;
&#xD;
          2. Age ≥18 years at the time of consent&#xD;
&#xD;
          3. Requiring standard of care intravenous insulin infusion therapy at the time of consent&#xD;
             with an anticipated duration of intravenous insulin infusion ≥12 hours&#xD;
&#xD;
          4. Willingness to provide informed consent and follow all study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current bleeding disorder, treatment with anticoagulants, or platelet count below&#xD;
             50,000/mL at enrollment&#xD;
&#xD;
          2. Lack of appropriate sites for sensor placement (sites must be free of scars, skin&#xD;
             irritation, surgical wounds, dressings, etc.)&#xD;
&#xD;
          3. Planned magnetic resonance imaging (MRI) study within 24 hours of enrollment&#xD;
&#xD;
          4. Any other condition that, based on Investigator's judgment, would jeopardize patient&#xD;
             safety during trial participation or would affect the study outcome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UC San Diego Medical Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>October 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Schafer Boeder</investigator_full_name>
    <investigator_title>Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

